GI
ONC icon

GAMMA Investing’s BeOne Medicines Ltd ONC Stock Holding History

GAMMA Investing’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$43.9K Buy
120
+34
+40% +$11.6K ﹤0.01% 2454
2026
Q2 		$24.5K Buy
86
+21
+32% +$6.19K ﹤0.01% 2732
2026
Q1 		$19.3K Hold
65
– – ﹤0.01% 2731
2025
Q4 		$19.7K Buy
65
+27
+71% +$8.84K ﹤0.01% 2621
2025
Q3 		$12.9K Hold
38
– – ﹤0.01% 2748
2025
Q2 		$9.2K Sell
38
-7
-16% -$1.72K ﹤0.01% 2850
2025
Q1 		$12.2K Sell
45
-22
-33% -$5.14K ﹤0.01% 2648
2024
Q4 		$12.4K Sell
67
-15
-18% -$3.06K ﹤0.01% 2495
2024
Q3 		$18.4K Buy
82
+43
+110% +$7.74K ﹤0.01% 2155
2024
Q2 		$5.56K Sell
39
-7
-15% -$1.08K ﹤0.01% 2533
2024
Q1 		$7.19K Buy
46
+27
+142% +$4.35K ﹤0.01% 2234
2023
Q4 		$2.82K Buy
+19
New +$3.44K ﹤0.01% 2469

Other funds holding ONC

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's ONC Position: Q3 2026 in Review

GAMMA Investing increased its BeOne Medicines Ltd (ONC) stake by 40% in Q3 2026, buying an estimated $11.6K and bringing the position to 120 shares worth $43.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2454.

GAMMA Investing first reported a position in ONC in Q4 2023 and has held it in 12 quarters since. 4 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • GAMMA Investing held 120 shares of BeOne Medicines Ltd worth $43.9K as of Q3 2026.
  • GAMMA Investing bought 34 BeOne Medicines Ltd shares in Q3 2026, an estimated $11.6K.
  • BeOne Medicines Ltd made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2454 holding.
  • GAMMA Investing first reported a position in BeOne Medicines Ltd in Q4 2023 and has held it in 12 quarters since.
  • 4 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.